Question 1

What is Cyclacel Pharmaceuticals Inc (CYCC) stock price today?

Accepted Answer

Cyclacel Pharmaceuticals Inc (CYCC) currently trades at $6.37 per share. The stock has a market capitalization of $14.25M and a P/E ratio of 0.00x.

Question 2

Is CYCC stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, Cyclacel Pharmaceuticals Inc has a Smart Value Score of 15/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

Question 3

What is the CYCC stock price target for 2026?

Accepted Answer

WallStSmart's 12-month price target for Cyclacel Pharmaceuticals Inc is $48,439.80.

Question 4

What is Cyclacel Pharmaceuticals Inc's revenue and earnings?

Accepted Answer

Cyclacel Pharmaceuticals Inc has trailing twelve-month (TTM) revenue of $10000.00 with profit margins of 0.00%. Earnings per share (EPS) is $7,123.50.

Metric	2021	2022	2023	2024	TTM
Revenue	$0.00	$373000.00	$420000.00	$43000.00	$10000.00
Net income	$-18.89M	$-21.20M	$-22.55M	$-11.21M	$-1.32M
EPS	—	—	—	—	$7,123.50
Free cash flow	$-18.57M	$-20.83M	$-16.12M	$-7.99M	$-1056.00
Profit margin	—	-5,683.11%	-5,370.24%	-26,074.42%	—

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CYCC	$14.25M	15	3.7	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Cyclacel Pharmaceuticals Inc

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare